In his most recent State of the Union address, President Obama announced a bold new research effort to revolutionize how we improve health and treat disease. According the White House website, the Precision Medicine Initiative, as it’s called, will pioneer a new model of patient-powered research that promises to accelerate biomedical discoveries and provide clinicians […]
Research, Science and Treatments
By Hedy Lee Kindler, MD, University of Chicago
The American Society of Clinical Oncology meeting was held from May 29 – June 2, 2015 in Chicago. About 30,000 attendees from across the world gathered to discuss the latest research advances in all types of cancer, making this the largest, most important oncology meeting of the year. […]
The Mesothelioma Applied Research Foundation would like to congratulate Dr. Lee M. Krug on his new position with Bristol-Myers Squibb (BMS), which he will be starting in August. He will be joining BMS as the Immuno-oncology Disease Head for Thoracic and GI Malignancies.
Dr. Krug will be leaving his position as an Associate Attending Physician in the […]
Aduro BioTech is conducting a clinical trial to test an investigational new immunotherapy for malignant pleural mesothelioma (MPM). This therapy, called CRS-207, is given to a patient in combination with chemotherapy in hopes of encouraging the body’s normal defense mechanisms to fight off the cancer. This trial aims to enroll up to 60 patients at […]
Alissa Bahr, a student at the University of Notre Dame, is this year’s recipient of special funding provided by the Meso Foundation and the International Association of Heat and Frost Insulators (Insulators), for a summer internship at the University of Chicago Medicine. She will be mentored by Drs. Kindler and Salgia, with whom she will […]